Largest hepatitis-C U.S. study defines optimal therapy
14th Nov 2005, 23:13 GMT
Final results of the WIN-R trial,[1] the largest hepatitis C study conducted in U.S. patients, showed that weight-based REBETOL (ribavirin, USP) in combination therapy with PEG-INTRON (peginterferon alfa-2b) achieved significantly higher rates of sustained virologic response (SVR)[2] and lower rates of relapse compared to the combination therapy using a flat dose of ribavirin.
Largest hepatitis-C U.S. study defines optimal therapy related news:
- NewYork-Presbyterian/Weill Cornell: Largest Hepatitis C Trial in U.S. Patients Shows Weight-Based REBETOL in Combination With PEG-INTRON Increases Sustained Response, Lowers Relapse — Market Wire - Pharmaceuticals and Biotech
- Hepatitis treatment studies' results announced — OnMedica Latest News
- Study touts animal therapy — USATODAY.com Video - In The News
- Can latest advances in health psychology help improve HIV care? — Medical News Today RSS/XML Feed
- Positive phase I trial for Schering-Plough HCV treatment — Pharmaceutical Business Review Online
- Volume 41, number 12: Physicians' Acceptable Treatment Failure Rates in Antibiotic Therapy for Coagulase-Negative Staphylococcal Catheter-Associated Bacteremia: Implications for Reducing Treatment Duration — Clin Infect Dis Latest Issue
- Optimal Initiation of Insulin in Type 2 Diabetes — Medscape Internal Medicine Headlines
- Tumor Necrosis Factor-[alpha] Promoter Polymorphism at Position -308 Predicts Response to Combination Therapy in Hepatitis C Virus Infection — J Infect Dis Latest Articles
- Patients more willing to consider self-injectable HIV therapy than many physicians anticipate, study — Medical News Today RSS/XML Feed
- AASLD: Hepatitis B Yields More to Telbivudine than Epivir — MedPage Today Infectious Disease
Latest news from News-Medical News Feed:
- Children being set up for heart disease later on in life
- New cancer treatments use body's own immune system to kill melanoma tumours
- IVF success compromised by heavy smoking
- Why we all carry on with those bad habits
- Sugar and fizzy drinks linked to pancreatic cancer
- SpectraScience files new patent application
- Global Patient Safety Challenge: Clean Care is Safer Care
- FDA strengthens program for medical devices
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer
- More U.S residents trust TV for health info